COVID-19 and Pregnancy: Placental and Immunological Impacts

NCT04726111 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2024-06-07

No results posted yet for this study

Summary

The aim of this study is to compare placental pathologies in patients with COVID 19 infection at the time of childbirth or a history of COVID 19 during pregnancy versus control patients

Conditions

  • Covid19

Interventions

OTHER

Specimens specific for the study

Specimens (blood, umbilical cord, umbilical cord blood, placenta)

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-30
Primary Completion
2021-07-30
Completion
2021-09-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04726111 on ClinicalTrials.gov